20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with hoe 33342 in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (hoe 33342) | Trials (hoe 33342) | Recent Studies (post-2010) (hoe 33342) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 1,270 | 0 | 245 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Leu, C; Li, Y; Tang, X; Wang, Z; Zheng, X; Zhu, D | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and hoe 33342
| Article | Year |
|---|---|
20-Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells.
Topics: Annexin A5; Apoptosis; Benzimidazoles; Blotting, Western; Caspase 3; Caspase 9; Chromatin; Coloring Agents; Culture Media, Serum-Free; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Membrane Potentials; Mitochondrial Membranes; Myocytes, Smooth Muscle; Propidium; Proto-Oncogene Proteins c-bcl-2; Pulmonary Artery; Tetrazolium Salts; Thiazoles | 2008 |